Effects of Pulmonary Rehabilitation in Salt Chambers on Functional Efficiency, Respiratory Parameters, and Blood Rheology in Elderly With Respiratory Diseases.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorUniversity School of Physical Education, Krakow, Poland

About this trial

The aim of the study is to assess the impact of the rehabilitation and treatment stay at the underground Health Resort of the 'Wieliczka' Salt Mine in Wieliczka on the functional capacity, respiratory parameters, and rheological properties of blood in elderly individuals with respiratory diseases.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

people aged 65 and older with chronic respiratory diseases in a stable period of the disease (without exacerbations), qualified to participate in a rehabilitation and treatment stay in the underground Health Resort 'Wieliczka' Salt Mine in Wieliczka,

patients who gave informed, written consent to participate in the study.

Disqualifiers

patients with contraindications to subterraneotherapy and physical exercise,

lack of written consent to participate in the study,

deterioration of health during the implementation of the program.

Trial design

Design model

Single group

Treatments tested in this trial

  • Subterranean, pulmonary rehabilitation

    Other intervention

    Pulmonary rehabilitation in the underground Health Resort of the 'Wieliczka' Salt Mine

Treatment groups

33 Participants
are divided into 1 treatment group
Group A: Subterranean, pulmonary rehabilitationOther 1 intervention

Trial outcomes

Primary outcomes

1

Respiratory muscle force: Maximal inspiratory pressure - MIP

This test involves wearing a nose peg and inhaling through a tube, performed in three trials.

Time frame
up to 18 months
2

Respiratory muscle force: Maximal expiratory pressure - MEP

This test involves wearing a nose peg and exhaling through a tube, performed in three trials.

Time frame
up to 18 months
3

Respiratory muscle force: Sniff Nasal Inspiratory Pressure - SNIP

The test consists of separate inhalations through the left and right nostrils, performed in five trials per nostril.

Time frame
up to 18 months
4

6-Minute Walk Test - 6MWT

The 6-Minute Walk Test (6MWT) is a standardized test used to assess functional exercise capacity. It measures the distance an individual can walk on a flat, hard surface in a period of six minutes

Time frame
up to 18 months

Secondary outcomes

1

FEV₁

Forced Expiratory Volume in One Second \[L\] - FEV₁ FEV₁ represents the volume of air forcibly exhaled during the first second of a forced expiratory maneuver, starting from full lung inflation. It is a key parameter in the assessment of airway obstruction and is used in the diagnosis and monitoring of diseases such as chronic obstructive pulmonary disease (COPD) and asthma. Lower FEV₁ values indicate narrowing of the airways or reduced lung function.

Time frame
2 weeks
2

FVC

Forced Vital Capacity \[L\] - FVC FVC is the total volume of air that can be forcibly exhaled after a full inspiration. It reflects the elastic properties of the lungs and chest wall. FVC is used in conjunction with FEV₁ to assess restrictive and obstructive ventilatory patterns. A reduced FVC may suggest lung restriction, while a low FEV₁/FVC ratio typically indicates airway obstruction.

Time frame
2 weeks
3

PEF

Peak Expiratory Flow \[L/min\] - PEF PEF represents the maximum flow rate achieved during a forced expiratory maneuver. It is a simple and reproducible indicator of large airway function and is often used in asthma monitoring, bronchodilator response testing, and occupational lung health assessments. Reduced PEF may indicate airway narrowing, poor effort, or respiratory muscle weakness.

Time frame
2 weeks
4

Bronchodilator Reversibility (BDR) Test

The bronchodilator reversibility test is performed to assess the responsiveness of the airways to bronchodilator medications, typically in patients suspected of having reversible airway obstruction, such as in asthma or chronic obstructive pulmonary disease (COPD). The test evaluates how spirometric values change following the administration of a bronchodilator (e.g., salbutamol or ipratropium), which relaxes smooth muscles and widens the airways.

Time frame
2 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.